Bon Natural Life Limited Receives NASDAQ Notification Regarding Independent Board Requirement
July 07 2023 - 3:30PM
Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"),
one of the leading bio-ingredient solutions providers in the
natural, health and personal care industries, today announced that
the Company received a letter (the “Notification Letter”) from the
Nasdaq Stock Market LLC (“Nasdaq”) on June 30, 2023, due to the
resignations of Messrs. James Edward Burns, Lawrence W. Leighton,
and Jeffrey J. Guzy from the Company’s Board of Directors and
respective committee assignments effective May 19, June 26, and
June 28, 2023, respectively, the Company no longer complies with
Nasdaq’s majority independent board and independent audit,
compensation, and nominating committee requirements as set forth in
Listing Rule 5605.
Under applicable Nasdaq rules, the Company has
until no later than August 14, 2023 to submit a plan to regain
compliance. If the plan is accepted, the Company may be granted an
extension of up to 180 calendar days from the date of the
Notification Letter to regain compliance.
The Company is in the process of identifying and
retaining new independent directors to serve on its board, and it
intends to have a majority independent board reimplemented within
the near future.
About Bon Natural Life
Limited
The Company focuses on the manufacturing of
personal care ingredients, such as plant extracted fragrance
compounds for perfume and fragrance manufacturers, natural health
supplements such as powder drinks and bioactive food ingredient
products mostly used as food additives and nutritional supplements
by their customers. For additional information, please visit the
Company’s website at www.bnlus.com.
Safe Harbor Statement
This press release contains forward-looking
statements as defined by the Private Securities Litigation Reform
Act of 1995. Forward-looking statements include statements
concerning plans, objectives, goals, strategies, future events or
performance, and underlying assumptions and other statements that
are other than statements of historical facts. When the Company
uses words such as "may, "will, "intend," "should," "believe,"
"expect," "anticipate," "project," "estimate" or similar
expressions that do not relate solely to historical matters, it is
making forward-looking statements. Forward-looking statements are
not guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's future
business development; product and service demand and acceptance;
changes in technology; economic conditions; the growth of the
natural, health and personal care market in China and the
other international markets the Company plans to serve; reputation
and brand; the impact of competition and pricing; government
regulations; fluctuations in general economic and business
conditions in China and the international markets the
Company plans to serve and assumptions underlying or related to any
of the foregoing and other risks contained in reports filed by the
Company with the SEC. For these reasons, among others, investors
are cautioned not to place undue reliance upon any forward-looking
statements in this press release. Additional factors are discussed
in the Company's filings with the SEC, which are available for
review at www.sec.gov. The Company undertakes no obligation to
publicly revise these forward–looking statements to reflect events
or circumstances that arise after the date hereof.
For more information, please
contact:
Bon Natural Lifebonnatural@appchem.cn
Bon Natural Life (NASDAQ:BON)
Historical Stock Chart
From Nov 2024 to Dec 2024
Bon Natural Life (NASDAQ:BON)
Historical Stock Chart
From Dec 2023 to Dec 2024